Nonprofit · EIN 35-2711268
INTREPID ALLIANCE INC
Tax-exempt · CAMBRIDGE, MA 02142
Financials
| Year ended | Form | Revenue | Expenses | Net income | Total assets | Liabilities | Net assets |
|---|---|---|---|---|---|---|---|
| December 31, 2024 | 990 | $2,245,192 | $1,930,908 | $314,284 | $2,256,819 | $126,649 | $2,130,170 |
| December 31, 2023 | 990 | $1,500,000 | $1,303,244 | $196,756 | $1,913,894 | $98,008 | $1,815,886 |
Financial details: 990 for the year ended December 31, 2024
Revenue
- Contributions, gifts and grants
- $0
- Program service revenue
- $2,250,000
- Investment income
- $0
- Other revenue
- -$4,808
Expenses
- Grants and similar amounts paid
- $0
- Compensation of officers, directors and key employees
- $298,844
- Other salaries and wages
- $1,156
- Salaries, compensation and benefits (total)
- $300,000
- Professional fundraising fees
- $0
- Legal fees
- $190,327
- Accounting fees
- $60,660
Balance sheet and other
- Total assets, start of year
- $1,913,894
- Total assets, end of year
- $2,256,819
- Total liabilities, end of year
- $126,649
- Net assets, end of year
- $2,130,170
- Gross receipts
- $2,245,192
- Employees
- 0
- Volunteers
- 21
- Year formed
- 2021
- State of legal domicile
- DE
From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.
Officers, directors and key employees
As listed on the 990 for the year ended December 31, 2024, highest compensation first.
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| NINA HILL | SECRETARIAT Officer | 40 | $298,844 |
| JAMES ANDERSON | PRESIDENT Trustee or director, Officer | 1 | $0 |
| LYDIA OGDEN | SECRETARY Trustee or director, Officer | 1 | $0 |
| DEREK WALLACE | DIRECTOR (AS OF 11/2024) Trustee or director | 1 | $0 |
| KENNETH BRADLEY | DIRECTOR Trustee or director | 1 | $0 |
| KUMAR SINGH SAIKATENDU | DIRECTOR (THRU 08/2024) Trustee or director | 1 | $0 |
| MARGARET CHU-MOYER | DIRECTOR Trustee or director | 1 | $0 |
| MICHELLE PARKS | DIRECTOR Trustee or director | 1 | $0 |
| SUJATA VAIDYANATHAN | DIRECTOR Trustee or director | 1 | $0 |
| TOMAS CIHLAR | DIRECTOR Trustee or director | 1 | $0 |
| JAMES BERGIN | TREASURER Officer | 1 | $0 |
990 for the year ended December 31, 2023: 12 people
| Name | Title | Hours / week | Compensation |
|---|---|---|---|
| NINA HILL | SECRETARIAT Officer | 40 | $319,996 |
| JAMES ANDERSON | PRESIDENT Trustee or director, Officer | 1 | $0 |
| JAMES BERGIN | TREASURER Trustee or director, Officer | 1 | $0 |
| LYDIA OGDEN | SECRETARY Trustee or director, Officer | 1 | $0 |
| KENNETH BRADLEY | DIRECTOR (AS OF 12/23) Trustee or director | 1 | $0 |
| TOMAS CIHLAR | DIRECTOR Trustee or director | 1 | $0 |
| MARGARET CHU-MOYER | DIRECTOR Trustee or director | 1 | $0 |
| RUXANDRA DRAGHIA-AKLI | DIRECTOR Trustee or director | 1 | $0 |
| MICHELLE PARKS | DIRECTOR Trustee or director | 1 | $0 |
| KUMAR SINGH SAIKATENDU | DIRECTOR Trustee or director | 1 | $0 |
| SUJATA VAIDYANATHAN | DIRECTOR Trustee or director | 1 | $0 |
| JOHN YOUNG | DIRECTOR (THRU 12/23) Trustee or director | 1 | $0 |
Address and contacts
- Address (IRS master file)
- 1 BROADWAY STE 14, CAMBRIDGE, MA 02142-1187
- In care of
- % BROWNE CONSULTING GROUP
- Principal officer (990 for 2024)
- JAMES ANDERSON, ONE BROADWAY 14TH FL, CAMBRIDGE, MA 01242
- Signed the 990
- JAMES BERGIN, TREASURER
- Phone
- (781) 757-2081
- Website
- INTREPIDALLIANCE.ORG
- Return prepared by
- BDO USA
Mission
THE PRIMARY PURPOSE OF THE CORPORATION IS TO PROMOTE THE COMMON BUSINESS INTEREST OF ITS MEMBERS OF ADVANCING GLOBAL HEALTH SECURITY THROUGH PANDEMIC PREPAREDNESS EFFORTS. THE CORPORATION WILL PURSUE THIS PURPOSE BY PROMOTING THE DEVELOPMENT OF NEW TREATMENTS FOR EMERGING VIRAL PANDEMIC PATHOGENS THROUGH COORDINATED EARLY SCIENCE, POLICY AND ADVOCACY, STAKEHOLDER ENGAGEMENT THAT FACILITATES INFORMATION SHARING, AND ADVANCING AND CREATING EFFICIENCIES IN EARLY RESEARCH AND DEVELOPMENT AMONG ITS MEMBERS AND OTHERS IN THE ANTIVIRAL R&D ECOSYSTEM. IN THIS WAY THE CORPORATION AIMS TO SUPPORT THE 100 DAY MISSION, AN INTERNATIONAL EFFORT BY THE INTERNATIONAL PANDEMIC PREPAREDNESS SECRETARIAT (IPPS.ORG) "TO PREPARE AS MUCH AS POSSIBLE SO THAT WITHIN THE FIRST 100 DAYS A PANDEMIC THREAT IS IDENTIFIED AN INITIAL REGIMEN OF THERAPEUTICS" CAN BE MADE AVAILABLE BY RESEARCH ENTERPRISES THAT ARE SAFE, EFFECTIVE AND AFFORDABLE.
Program accomplishments
- BEYOND COVID-19, GLOBALIZATION, URBAN EXPANSION, AND EXPLOITATION OF NATURAL HABITATS SUGGEST HUMANITY WILL FACE NEW FORMS OF RESPIRATORY AND OTHER PATHOGENS THAT HOLD THE POTENTIAL TO CAUSE PANDEMICS. ORALLY AVAILABLE SMALL-MOLECULE ANTIVIRAL DRUGS FOR RAPID MOBILIZATION AND DISTRIBUTION ARE A CRITICAL TOOL TO PROTECT SOCIETIES FROM ANOTHER VIRAL PANDEMIC. UNLIKE SOME VACCINES AND ANTIBODIES, ANTIVIRAL THERAPIES MIGHT BE LESS PRONE TO THE IMPACT OF VIRUS GENETIC EVOLUTION, MAY BE EFFECTIVE AGAINST A BROAD RANGE OF VIRUSES, AND CAN CHANGE THE COURSE OF DISEASE EVEN AFTER INFECTION. MOST SMALL MOLECULE ANTIVIRALS CAN BE PRODUCED RAPIDLY AND COST-EFFECTIVELY AT A GLOBAL SCALE IN EXISTING FACILITIES, BUT THEY REQUIRE YEARS TO DISCOVER AND DEVELOP, SO IT IS CRITICAL TO PROMOTE AND SUPPORT RESEARCH, ADVOCACY, AND SCIENTIFIC INFORMATION SHARING ACROSS THE ACADEMIC BIOTECH AND PHARMACEUTICAL INDUSTRY. IN ORDER TO CREATE EFFICIENCIES IN THE R&D ECOSYSTEM, THE CORPORATION WILL COLLABORATE WITH PARTNERS IN OTHER SECTORS AND ITS MEMBERS IN EXPLORING REDUNDANCIES AND OPPORTUNITIES TO COLLABORATE FOR THE BENEFIT OF HUMANITY SUCH AS SHARING NEW RESEARCH FINDINGS, CREATING GUIDELINES SUCH AS TARGET PRODUCT PROFILES, BENCHMARKING GLOBAL R&D EFFORTS AGAINST PATHOGENS OF PANDEMIC CONCERN AND CREATING A LISTING OF PROMISING LEAD PRODUCT CANDIDATES BY RESEARCHERS GLOBALLY. WE HOPE TO ACCELERATE THE COLLECTIVE UNDERSTANDING OF VIRAL TARGETS AND INCREASE THE LIKELIHOOD OF THE R&D ECOSYSTEM IN IDENTIFYING PROMISING LEADS. THE CORPORATION INTENDS TO FACILITATE FURTHER SCIENTIFIC INFORMATION SHARING BY DEVELOPING WHITE PAPERS ON RELEVANT TOPICS, PERFORMING A LANDSCAPE AND NEEDS ASSESSMENT ACROSS PUBLIC AND PRIVATE ANTIVIRAL RESEARCH SECTORS, AND PROVIDING KNOWLEDGE-SHARING OPPORTUNITIES THROUGH ORGANIZING MEETINGS AND SEMINARS. THE CORPORATION ALSO ORGANIZED AND PRODUCED A GLOBAL SUMMIT ON ANTIVIRAL PREPAREDNESS FOR 100 STAKEHOLDERS, PUBLISHED AND DISSEMINATED THE ANTIVIRAL SUMMIT PROCEEDINGS AND RECOMMENDATIONS, RESEARCHED, ANALYZED AND AUTHORED THE ANTIVIRAL CLINICAL DEVELOPMENT LANDSCAPE FOR PUBLICATION IN JANUARY 2024 AND DEVELOPED A TARGET COMPOUND PROFILE TO GUIDE ACADEMIC, BIOTECH, PHARMA AND GOVERNMENT DRUG DEVELOPERS IN THEIR R&D FOR ANTIVIRALS.
What it must file and when
IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.
| Tax year | Year ended | Due | IRS public records |
|---|---|---|---|
| 2025 | December 31, 2025 | May 15, 2026 | Not on file |
| 2024 | December 31, 2024 | May 15, 2025 | 990 on file |
| 2023 | December 31, 2023 | May 15, 2024 | 990 on file |
IRS record
- EIN
- 35-2711268
- Tax-exempt status
- 501(c)(6): Business league or chamber of commerce
- Donations deductible
- No
- Exempt since
- 2023
- Accounting year ends
- December
- Files
- Form 990 or 990-EZ
- Category (NTEE)
- Medical research (H03)
- Assets (IRS master file)
- $2,256,819
- Income (IRS master file)
- $2,245,192
Filing history
| Form | Year ended | Revenue | Expenses | Assets | Return |
|---|---|---|---|---|---|
| 990 | December 2024 | $2,245,192 | $1,930,908 | $2,256,819 | XML |
| 990 | December 2023 | $1,500,000 | $1,303,244 | $1,913,894 | XML |
| 990 | December 2022 | $1,499,980 | $236,250 | $1,648,182 | IRS |
| 990 | December 2021 | $500,000 | $47,600 | $500,000 | IRS |
990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 35-2711268).
Questions about INTREPID ALLIANCE INC
- What is the EIN of INTREPID ALLIANCE INC?
- The employer identification number (EIN) of INTREPID ALLIANCE INC is 35-2711268.
- Is INTREPID ALLIANCE INC tax-exempt?
- Yes. The IRS lists it as tax-exempt under section 501(c)(6) since 2023.
- Are donations to INTREPID ALLIANCE INC tax-deductible?
- No. The IRS master file says contributions to it are not deductible.
- Which annual return does INTREPID ALLIANCE INC file?
- Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
- When is the next return of INTREPID ALLIANCE INC due?
- The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
- When did INTREPID ALLIANCE INC last file with the IRS?
- The latest return in the IRS public files is the 990 for the year ended December 2024.
- Who is the principal officer of INTREPID ALLIANCE INC?
- The 990 for the year ended December 31, 2024 names JAMES ANDERSON.
- Who are the officers and directors of INTREPID ALLIANCE INC?
- The 990 for the year ended December 31, 2024 lists 11 people; 1 received compensation from the organization, the highest $298,844 (NINA HILL, SECRETARIAT).
- How much revenue does INTREPID ALLIANCE INC have?
- On its 990 for the year ended December 31, 2024 it reported revenue of $2,245,192, expenses of $1,930,908 and total assets of $2,256,819 at year end.
Other nonprofits in CAMBRIDGE
- BROAD INSTITUTE INC EIN 26-3428781 · last filed 990 for 2025
- WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH EIN 06-1043412 · last filed 990 for 2025
- LIFE SCIENCE CARES INC EIN 81-2435939 · last filed 990 for 2024
- COUNT ME IN INC EIN 83-0561457 · last filed 990 for 2023
- CENTER FOR HUMAN GENETICS INC EIN 04-3154223 · last filed 990 for 2025
- ACTIVE SITE RESEARCH INC EIN 93-2180352 · last filed 990 for 2025
- COLLABORATIVE TRAJECTORY ANALYSIS PROJECT EIN 93-4558784 · last filed 990 for 2024
- TARGETCANCER FOUNDATION INC EIN 26-4510094 · last filed 990 for 2025
All nonprofits in CAMBRIDGE · Massachusetts · Medical research